Retraction.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

19 citing papers in PubMed, 48 citations in OpenAlex.

1. If this is true, what does it imply? How end-user antibody validation facilitates insights into biology and disease.Asian journal of urology · 2019
   Review
2. Problems with precaution: the transfusion medicine experience.Journal of risk research · 2019
   Article
3. Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS).Journal of translational medicine · 2018
   Review
4. Improving the standardization of mRNA measurement by RT-qPCR.Biomolecular detection and quantification · 2018
   Article
5. XMRV and Public Health: The Retroviral Genome Is Not a Suitable Template for Diagnostic PCR, and Its Association with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Appears Unreliable.Frontiers in public health · 2017
   Article
6. Xenotropic Murine Leukemia Virus-Related Virus (XMRV) and the Safety of the Blood Supply.Clinical microbiology reviews · 2016
   Review
7. The use of preliminary scientific evidence in public health: a case study of XMRV.PLoS medicine · 2014
   Article
8. New immunotherapeutic paradigms for castration-resistant prostate cancer.Oncoimmunology · 2013
   Article
9. Partial molecular cloning of the JHK retrovirus using gammaretrovirus consensus PCR primers.Future virology · 2013
   Article
10. No association between XMRV or related gammaretroviruses in Australian prostate cancer patients.Virology journal · 2013
    Article
11. Emerging pathogens and their implications for the blood supply and transfusion transmitted infections.British journal of haematology · 2012
    Review
12. [Etiopathogenetic aspects of somatoform disorders].Der Nervenarzt · 2012
    Article
13. No evidence for xenotropic murine leukemia-related virus infection in Sweden using internally controlled multiepitope suspension array serology.Clinical and vaccine immunology : CVI · 2012
    Article
14. No evidence for the involvement of XMRV or MCV in the pathogenesis of breast cancer.British journal of cancer · 2012
    Article
15. No biological evidence of XMRV infection in cervical smears from HIV/ HPV positive and negative Kenyan women.PloS one · 2012
    Article
16. Susceptibility of human lymphoid tissue cultured ex vivo to xenotropic murine leukemia virus-related virus (XMRV) infection.PloS one · 2012
    Article
17. No biological evidence of XMRV in blood or prostatic fluid from prostate cancer patients.PloS one · 2012
    Article
18. Absence of XMRV and closely related viruses in primary prostate cancer tissues used to derive the XMRV-infected cell line 22Rv1.PloS one · 2012
    Article
19. No evidence for infection of UK prostate cancer patients with XMRV, BK virus, Trichomonas vaginalis or human papilloma viruses.PloS one · 2012
    Article

Corrections and comments

• Retraction of
  RETRACTED: Detection of an infectious retrovirus, XMRV, in blood cells of patients with chronic fatigue syndrome.2009

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract